Chris Burkitt

Chris Burkitt, CPA, CA, currently serves as the Head of Group Controlling, Reporting & FP&A at Corden Pharma since July 2022. Previously, Chris held several key finance roles at Catalent Pharma Solutions, including Global Finance Manager for the A2R Catalyst Project and Finance Manager for Switzerland, overseeing significant sales across multiple business units. Additional experience includes interim management at PageGroup, financial leadership at Celestica, and various accounting positions at Stephenson's Rental Services, PEACE ARCH ENTERTAINMENT GRP, and Aluma Systems. Chris began a career in accounting with Shimmerman Penn LLP and Collins Barrow. Chris holds an Honours Bachelor of Business Administration in Accounting and Finance from Wilfrid Laurier University.